Cargando…
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question
For several decades, the treatment for acute myeloid leukemia (AML) has been a dichotomous choice between intensive chemotherapy strategies with curative intent and non-intensive options including supportive care. Patients’ age and fitness, as well as comorbidities, primarily influenced this choice....
Autores principales: | Jaramillo, Sonia, Schlenk, Richard F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890037/ https://www.ncbi.nlm.nih.gov/pubmed/36722404 http://dx.doi.org/10.3324/haematol.2022.280802 |
Ejemplares similares
-
Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?
por: Jaramillo, Sonia, et al.
Publicado: (2021) -
Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies
por: Pettit, Kristen, et al.
Publicado: (2015) -
Updates on the Management of Acute Myeloid Leukemia
por: Huerga-Domínguez, Sofía, et al.
Publicado: (2022) -
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges
por: Schlenk, Richard F.
Publicado: (2023) -
Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia
por: Tober, Romy, et al.
Publicado: (2022)